VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate

This analysis evaluates the effects on lipoprotein subfractions and LDL particle size of ezetimibe/simvastatin with or without coadministration of fenofibrate in patients with mixed hyperlipidemia. This multicenter, double-blind, placebo-controlled, parallel-group study included 611 patients aged 18...

Full description

Bibliographic Details
Main Authors: Michel Farnier, Inna Perevozskaya, William V. Taggart, Debra Kush, Yale B. Mitchel
Format: Article
Language:English
Published: Elsevier 2008-12-01
Series:Journal of Lipid Research
Subjects:
Vertical Auto Profile II
statin
cholesterol absorption inhibition
fibrates
lipids
atherogenic
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520345946

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520345946

Similar Items